Design Therapeutics (DSGN) Other Non-Current Assets (2020 - 2025)

Design Therapeutics has reported Other Non-Current Assets for 4 years, with the latest figure at $427000.0 in Q1 2025.

• Other Non-Current Assets for Q1 2025 came in at $427000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2025 was $427000.0 (changed 0.0% YoY), and the FY2024 annual result was $427000.0, down 0.7% from the prior year.
• Other Non-Current Assets steadied at $427000.0 in Q1 2025, from $427000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $474000.0 in Q2 2022 and troughed at $427000.0 in Q1 2024.
• A 4-year average of $441583.3 and a median of $433500.0 in 2023 frame the typical range for Other Non-Current Assets.
• The widest annual swing landed in 2023, when Other Non-Current Assets fell 6.33%; it then changed 0.0% in 2025.
• A 4-year view of Other Non-Current Assets shows it stood at $459000.0 in 2022, then slipped by 6.32% to $430000.0 in 2023, then declined by 0.7% to $427000.0 in 2024, then changed by 0.0% to $427000.0 in 2025.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $427000.0 in Q1 2025, $427000.0 in Q4 2024, and $427000.0 in Q3 2024.